Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-25

Clinical Trial Update: Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating terazosin as a treatment for hyperhidrosis (excessive sweating) induced by antidepressants, including measurements of sweating symptoms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terazosin (terazosin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Hyperhidrosis | Phase 4 | Status: COMPLETED